Výsledky vyhledávání - "David Gorenstein"

Akademický článek

Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report

Autor: Jock Chichaco Kuruc, Armando A. Durant-Archibold, Jorge Motta, K. S. Rao, Barry Trachtenberg, Carlos Ramos, Hongyu Wang, David Gorenstein, Fredrik Vannberg, King Jordan

Publikováno v: BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-5 (2019)

Abstract Background Anthracyclines are highly effective anticancer medication prescribed for the treatment of breast cancer. Nevertheless, the use of anthracyclines as chemotherapeutic agents involves a risk for development of cardiac toxicity which

Externí odkaz: https://doaj.org/article/c13aea2961244d9aa8fcbfaad8b98605

Zobrazit plný text záznamu

Akademický článek

Conjugate-SELEX: A High-throughput Screening of Thioaptamer-liposomal Nanoparticle Conjugates for Targeted Intracellular Delivery of Anticancer Drugs

Autor: Qingshan Mu, Akshaya Annapragada, Mayank Srivastava, Xin Li, Jean Wu, Varatharasa Thiviyanathan, Hongyu Wang, Alexander Williams, David Gorenstein, Ananth Annapragada, Nadarajah Vigneswaran

Publikováno v: Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)

Patients with advanced head and neck squamous cell carcinoma receiving chemotherapy have a poor prognosis partly due to normal tissue toxicity; therefore, development of a tumor-targeted drug delivery platform to minimize collateral toxicity is a goa

Externí odkaz: https://doaj.org/article/e0471b11aea542e98b16c126d2e5489e

Zobrazit plný text záznamu

Akademický článek

Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein.

Autor: Susmita Samanta, Kurtis Anderson, Sean Moran, David Hawke, David Gorenstein, Myriam Fornage

Publikováno v: PLoS ONE, Vol 7, Iss 8, p e42417 (2012)

Sequence variation in the human 12/15 lipoxygenase (ALOX15) has been associated with atherosclerotic disease. We functionally characterized an ALOX15 promoter polymorphism, rs2255888, previously associated with carotid plaque burden.We demonstrate sp

Externí odkaz: https://doaj.org/article/b24eed02dcf746d88fc925ebabbcdd59

Zobrazit plný text záznamu

Alliance for NanoHealth (ANH) Training Program for the development of future generations of interdisciplinary scientists and collaborative research focused upon the advancement of nanomedicine

Autor: David Gorenstein

This program • Offered summer internship training for three undergraduate students in alliance with MD Anderson Step-Up program. • Awarded 2-year fellowships to two graduate students for collaborative, interdisciplinary research in specific areas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::904124cd5852a836f8be5cc2276849a2
https://doi.org/10.2172/1132629

Zobrazit plný text záznamu

Abstract P259: Functional Characterization of an ALOX15 Promoter Variant Associated with Coronary Artery Calcification: Regulation of ALOX15 by Vimentin

Autor: Susmita Samanta, Kurtis Anderson, Sean Moran, David Gorenstein, Myriam Fornage

Publikováno v: Circulation Research. 109

Human 12/15-lipoxygenase (ALOX15) catalyzes the oxidation of polyunsaturated fatty acids and has been implicated in the pathogenesis of atherosclerosis. We previously reported that a common haplotype of the ALOX15 gene is associated with higher preva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5952ef468c655b2676003871ee72d835
https://doi.org/10.1161/res.109.suppl_1.ap259

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání